世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

塞栓療法の世界市場：適応症別（癌、消化器疾患、神経疾患、末梢血管疾患、泌尿器・腎臓疾患）、製品別（塞栓剤、サポートデバイス）、タイプ別（化学塞栓、放射線塞栓、動脈塞栓、併用）、エンドユーザー別（病院、クリニック、外科外来センター、その他）、地域別、予測・機会、2025年


Global Embolotherapy Market By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders), By Product (Embolic Agents, Support Devices), By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others), By Region, Forecast & Opportunities, 2025

世界の塞栓療法市場は、慢性疾患の発生率の上昇、患者数の増加、医療費の高騰などの要因により、予測期間中に大きなCAGRを記録すると予想されています。さらに、塞栓療法装置の急速な技術進歩も、2025年までの市... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ 		2022年7月1日 US$4,900
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		112 英語

　

サマリー

世界の塞栓療法市場は、慢性疾患の発生率の上昇、患者数の増加、医療費の高騰などの要因により、予測期間中に大きなCAGRを記録すると予想されています。さらに、塞栓療法装置の急速な技術進歩も、2025年までの市場成長を後押しすると予測されています。

塞栓療法は、異常な血液細胞を抑制またはブロックすることにより、出血を抑制し、腫瘍を縮小するために用いられる血管内治療法の一種です。ブロッキングを達成するために、塞栓療法は低侵襲な方法と、ゲルフォーム、コイル、バルーン、血管造影カテーテルなどの塞栓剤を使用して、良好な結果を得ることができます。さらに、中間期や進行期と診断された患者のほとんどが根治療法に反応しないため、様々な疾患の管理における塞栓処置の採用が急速に増加しています。

世界の塞栓療法市場は、塞栓療法に伴うリスクや課題、熟練した放射線技師の不足など、いくつかの阻害要因に直面しています。また、不利な規制シナリオも、塞栓療法市場の成長に課題を与える可能性があります。

世界の塞栓療法市場は、適応症、製品、タイプ、エンドユーザー、地域に基づいて区分されます。エンドユーザーに基づいて、市場は病院、診療所、外来手術センター、その他に区分されます。2019年、世界の塞栓療法市場において、病院カテゴリが最大の市場シェアを占めています。この背景には、病院が推進する低侵襲な処置の採用が拡大していることが挙げられます。
世界の塞栓療法市場で事業を展開している主な企業は、Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc. Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation などである。各社は、市場シェアを拡大するために新製品の研究開発に取り組んでいます。また、パートナーシップ、戦略的買収などの他の成長戦略は、企業が世界の塞栓療法市場で存在感を高めるのに役立っています。
本レポートで考慮した年数
歴史的年数：2015年～2018年
基準年：2019年
推定年：2020年
予測期間：2021年～2025年
調査の目的
- 世界の塞栓療法の市場規模を分析・予測するため。
- 適応症、製品、タイプ、エンドユーザー、地域分布に基づく世界の塞栓療法市場の分類と予測を行うこと。
- 世界の塞栓療法市場の促進要因と課題を特定する。
- 世界の塞栓療法市場における事業拡大、新製品投入、M&Aなどの競争展開を検討するため。
- 世界の塞栓療法市場の価格分析を行うため。
- 世界の塞栓療法市場で活動する主要企業のプロファイルを特定および分析すること。
TechSci Researchは、この調査のために一次調査と徹底的な二次調査の両方を実施しました。最初に、TechSci Researchは世界中の病院/クリニックのリストを入手しました。その後、TechSci Researchは特定された企業に対して一次調査の調査を実施しました。インタビューを行う際に、回答者には競合他社についても質問しました。この手法により、TechSci Research は、二次調査の制限により特定できなかった病院/診療所を含めることができました。TechSci Researchは、世界中の病院/診療所とすべての主要なプレーヤーの存在を分析しました。
TechSci Researchは、様々なエンドユーザーセグメントのデータを記録し、将来の予測を行うボトムアップアプローチを用いて、世界の塞栓療法市場の市場規模を算出した。TechSci Researchは、これらの値を業界の専門家や企業の代表者から入手し、適切で全体的な市場規模を得るためにこれらの製品タイプやアプリケーションの履歴データを分析することで外部的に検証した。企業のウェブサイト、ニュース記事、プレスリリース、企業の年次報告書、投資家向けプレゼンテーション、財務報告書など、さまざまな二次資料もTechSci Researchによって調査されました。
主な対象読者
- 塞栓療法の病院/クリニック、研究機関、その他の関係者
- 規制当局や政策立案者などの政府機関
- 塞栓療法に関連する組織、フォーラム、アライアンス
- 市場調査会社、コンサルティング会社
本調査は、病院/クリニック、パートナー、エンドユーザーなどの業界関係者にとって重要ないくつかの重要な質問に対する回答を提供し、さらに、投資の戦略立案や市場機会の活用を可能にする上で有用です。
レポートの範囲
本レポートでは、塞栓療法の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。
- 市場、適応症別
o 癌
o 消化器系疾患
o 神経系疾患
o 神経系疾患 o 末梢血管系疾患
o 泌尿器系・腎臓系疾患
- 市場、製品別
o 塞栓剤
塞栓用コイル
塞栓用プラグシステム
液体塞栓剤
マイクロスフェアー
着脱式バルーン
サポートデバイス
マイクロカテーテル
ガイドワイヤー
- 市場、タイプ別
o 化学塞栓療法
o 放射線塞栓療法
o 動脈塞栓療法
o コンビネーション
- 市場、エンドユーザー別
o 病院
o クリニック
o 外来手術センター
o その他
- 市場、地域別
o 北米
米国
カナダ
メキシコ
o ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
o アジア太平洋地域
中国
日本
インド
韓国
シンガポール
オーストラリア
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
o 南米
ブラジル
アルゼンチン
コロンビア

競合他社の状況
企業プロファイル。世界の塞栓療法市場に存在する主要企業の詳細分析
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。本レポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング（最大5社まで）。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Embolotherapy Market
4. Executive Summary
5. Voice of Customer
6. Global Embolotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Embolotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Embolic agents
7.2.3. By Types
7.2.4. By End-User
7.2.5. By Country
7.3. Market Attractiveness Index
7.4. Asia-Pacific: Country Analysis
7.4.1. China Embolotherapy Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Indication
7.4.1.2.2. By Embolic agents
7.4.1.2.3. By Types
7.4.1.2.4. By End-User
7.4.2. India Embolotherapy Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Indication
7.4.2.2.2. By Embolic agents
7.4.2.2.3. By Types
7.4.2.2.4. By End-User
7.4.3. Japan Embolotherapy Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Indication
7.4.3.2.2. By Embolic agents
7.4.3.2.3. By Types
7.4.3.2.4. By End-User
7.4.4. South Korea Embolotherapy Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Indication
7.4.4.2.2. By Embolic agents
7.4.4.2.3. By Types
7.4.4.2.4. By End-User
7.4.5. Singapore Embolotherapy Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Indication
7.4.5.2.2. By Embolic agents
7.4.5.2.3. By Types
7.4.5.2.4. By End-User
7.4.6. Australia Embolotherapy Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Indication
7.4.6.2.2. By Embolic agents
7.4.6.2.3. By Types
7.4.6.2.4. By End-User
8. Europe Embolotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Embolic agents
8.2.3. By Types
8.2.4. By End-User
8.2.5. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. France Embolotherapy Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Indication
8.4.1.2.2. By Embolic agents
8.4.1.2.3. By Types
8.4.1.2.4. By End-User
8.4.2. Germany Embolotherapy Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Indication
8.4.2.2.2. By Embolic agents
8.4.2.2.3. By Types
8.4.2.2.4. By End-User
8.4.3. United Kingdom Embolotherapy Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Indication
8.4.3.2.2. By Embolic agents
8.4.3.2.3. By Types
8.4.3.2.4. By End-User
8.4.4. Italy Embolotherapy Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Indication
8.4.4.2.2. By Embolic agents
8.4.4.2.3. By Types
8.4.4.2.4. By End-User
8.4.5. Russia Embolotherapy Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Indication
8.4.5.2.2. By Embolic agents
8.4.5.2.3. By Types
8.4.5.2.4. By End-User
8.4.6. Spain Embolotherapy Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Indication
8.4.6.2.2. By Embolic agents
8.4.6.2.3. By Types
8.4.6.2.4. By End-User
9. North America Embolotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Embolic agents
9.2.3. By Types
9.2.4. By End-User
9.2.5. By Country
9.3. Market Attractiveness Index
9.4. North America: Country Analysis
9.4.1. United States Embolotherapy Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Indication
9.4.1.2.2. By Embolic agents
9.4.1.2.3. By Types
9.4.1.2.4. By End-User
9.4.2. Mexico Embolotherapy Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Indication
9.4.2.2.2. By Embolic agents
9.4.2.2.3. By Types
9.4.2.2.4. By End-User
9.4.3. Canada Embolotherapy Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Indication
9.4.3.2.2. By Embolic agents
9.4.3.2.3. By Types
9.4.3.2.4. By End-User
10. South America Embolotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Embolic agents
10.2.3. By Types
10.2.4. By End-User
10.2.5. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Embolotherapy Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Indication
10.4.1.2.2. By Embolic agents
10.4.1.2.3. By Types
10.4.1.2.4. By End-User
10.4.2. Argentina Embolotherapy Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Indication
10.4.2.2.2. By Embolic agents
10.4.2.2.3. By Types
10.4.2.2.4. By End-User
10.4.3. Colombia Embolotherapy Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Indication
10.4.3.2.2. By Embolic agents
10.4.3.2.3. By Types
10.4.3.2.4. By End-User
11. Middle East and Africa Embolotherapy Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Embolic agents
11.2.3. By Types
11.2.4. By End-User
11.2.5. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. South Africa Embolotherapy Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Indication
11.4.1.2.2. By Embolic agents
11.4.1.2.3. By Types
11.4.1.2.4. By End-User
11.4.2. Saudi Arabia Embolotherapy Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Indication
11.4.2.2.2. By Embolic agents
11.4.2.2.3. By Types
11.4.2.2.4. By End-User
11.4.3. UAE Embolotherapy Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Indication
11.4.3.2.2. By Embolic agents
11.4.3.2.3. By Types
11.4.3.2.4. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Abbott Laboratories
14.2.2. ABK Biomedical Inc
14.2.3. Acandis GmbH
14.2.4. AngioDynamics Inc
14.2.5. Becton Dickinson and Company
14.2.6. Boston Scientific Corporation
14.2.7. Cook Medical
14.2.8. Guerbet
14.2.9. Imbiotechnologies Ltd.
14.2.10. Johnson & Johnson
14.2.11. Kaneka Corporation
14.2.12. Medtronic
14.2.13. Meril Life Sciences Pvt. Ltd.
14.2.14. Merit Medical Systems
14.2.15. Merit Medical Systems, Inc.
14.2.16. Penumbra, Inc.
14.2.17. Simbionix USA Corporation
14.2.18. Sirtex Medical Limited
14.2.19. Stryker Corporation
14.2.20. Terumo Corporation
15. Strategic Recommendations
16. About Us & Disclaimer

　

ページTOPに戻る


　

Summary

Global embolotherapy market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.

Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.

The global embolotherapy market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.

The global embolotherapy market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the global embolotherapy market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.
Major players operating in the global embolotherapy market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the global embolotherapy market.
Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
• To analyze and forecast the market size of global embolotherapy market.
• To classify and forecast global embolotherapy market based on indication, product, type, end-user and regional distribution.
• To identify drivers and challenges for global embolotherapy market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global embolotherapy market.
• To conduct pricing analysis for global embolotherapy market.
• To identify and analyze the profile of leading players operating in global embolotherapy market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.
TechSci Research calculated the market size of global embolotherapy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience:
• Embolotherapy hospitals/clinics, research organizations and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to embolotherapy
• Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, global embolotherapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• Market, By Indication:
o Cancer
o Gastrointestinal Disorders
o Neurological Diseases
o Peripheral Vascular Disease
o Urological & Nephrological Disorders
• Market, By Product:
o Embolic Agents
 Embolic Coils
 Embolic Plug Systems
 Liquid Embolic Agents
 Microspheres
 Detachable Balloons
o Support Devices
 Microcatheters
 Guidewires
• Market, By Type:
o Chemoembolization
o Radioembolization
o Arterial Embolization
o Combination
• Market, By End-User:
o Hospitals
o Clinics
o Ambulatory Surgical Centers
o Others
• Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 Germany
 France
 United Kingdom
 Italy
 Spain
 Russia
o Asia-Pacific
 China
 Japan
 India
 South Korea
 Singapore
 Australia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
o South America
 Brazil
 Argentina
 Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in global embolotherapy market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Embolotherapy Market
4. Executive Summary
5. Voice of Customer
6. Global Embolotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Embolotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Embolic agents
7.2.3. By Types
7.2.4. By End-User
7.2.5. By Country
7.3. Market Attractiveness Index
7.4. Asia-Pacific: Country Analysis
7.4.1. China Embolotherapy Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Indication
7.4.1.2.2. By Embolic agents
7.4.1.2.3. By Types
7.4.1.2.4. By End-User
7.4.2. India Embolotherapy Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Indication
7.4.2.2.2. By Embolic agents
7.4.2.2.3. By Types
7.4.2.2.4. By End-User
7.4.3. Japan Embolotherapy Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Indication
7.4.3.2.2. By Embolic agents
7.4.3.2.3. By Types
7.4.3.2.4. By End-User
7.4.4. South Korea Embolotherapy Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Indication
7.4.4.2.2. By Embolic agents
7.4.4.2.3. By Types
7.4.4.2.4. By End-User
7.4.5. Singapore Embolotherapy Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Indication
7.4.5.2.2. By Embolic agents
7.4.5.2.3. By Types
7.4.5.2.4. By End-User
7.4.6. Australia Embolotherapy Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Indication
7.4.6.2.2. By Embolic agents
7.4.6.2.3. By Types
7.4.6.2.4. By End-User
8. Europe Embolotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Embolic agents
8.2.3. By Types
8.2.4. By End-User
8.2.5. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. France Embolotherapy Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Indication
8.4.1.2.2. By Embolic agents
8.4.1.2.3. By Types
8.4.1.2.4. By End-User
8.4.2. Germany Embolotherapy Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Indication
8.4.2.2.2. By Embolic agents
8.4.2.2.3. By Types
8.4.2.2.4. By End-User
8.4.3. United Kingdom Embolotherapy Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Indication
8.4.3.2.2. By Embolic agents
8.4.3.2.3. By Types
8.4.3.2.4. By End-User
8.4.4. Italy Embolotherapy Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Indication
8.4.4.2.2. By Embolic agents
8.4.4.2.3. By Types
8.4.4.2.4. By End-User
8.4.5. Russia Embolotherapy Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Indication
8.4.5.2.2. By Embolic agents
8.4.5.2.3. By Types
8.4.5.2.4. By End-User
8.4.6. Spain Embolotherapy Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Indication
8.4.6.2.2. By Embolic agents
8.4.6.2.3. By Types
8.4.6.2.4. By End-User
9. North America Embolotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Embolic agents
9.2.3. By Types
9.2.4. By End-User
9.2.5. By Country
9.3. Market Attractiveness Index
9.4. North America: Country Analysis
9.4.1. United States Embolotherapy Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Indication
9.4.1.2.2. By Embolic agents
9.4.1.2.3. By Types
9.4.1.2.4. By End-User
9.4.2. Mexico Embolotherapy Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Indication
9.4.2.2.2. By Embolic agents
9.4.2.2.3. By Types
9.4.2.2.4. By End-User
9.4.3. Canada Embolotherapy Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Indication
9.4.3.2.2. By Embolic agents
9.4.3.2.3. By Types
9.4.3.2.4. By End-User
10. South America Embolotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Embolic agents
10.2.3. By Types
10.2.4. By End-User
10.2.5. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Embolotherapy Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Indication
10.4.1.2.2. By Embolic agents
10.4.1.2.3. By Types
10.4.1.2.4. By End-User
10.4.2. Argentina Embolotherapy Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Indication
10.4.2.2.2. By Embolic agents
10.4.2.2.3. By Types
10.4.2.2.4. By End-User
10.4.3. Colombia Embolotherapy Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Indication
10.4.3.2.2. By Embolic agents
10.4.3.2.3. By Types
10.4.3.2.4. By End-User
11. Middle East and Africa Embolotherapy Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Embolic agents
11.2.3. By Types
11.2.4. By End-User
11.2.5. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. South Africa Embolotherapy Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Indication
11.4.1.2.2. By Embolic agents
11.4.1.2.3. By Types
11.4.1.2.4. By End-User
11.4.2. Saudi Arabia Embolotherapy Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Indication
11.4.2.2.2. By Embolic agents
11.4.2.2.3. By Types
11.4.2.2.4. By End-User
11.4.3. UAE Embolotherapy Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Indication
11.4.3.2.2. By Embolic agents
11.4.3.2.3. By Types
11.4.3.2.4. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Abbott Laboratories
14.2.2. ABK Biomedical Inc
14.2.3. Acandis GmbH
14.2.4. AngioDynamics Inc
14.2.5. Becton Dickinson and Company
14.2.6. Boston Scientific Corporation
14.2.7. Cook Medical
14.2.8. Guerbet
14.2.9. Imbiotechnologies Ltd.
14.2.10. Johnson & Johnson
14.2.11. Kaneka Corporation
14.2.12. Medtronic
14.2.13. Meril Life Sciences Pvt. Ltd.
14.2.14. Merit Medical Systems
14.2.15. Merit Medical Systems, Inc.
14.2.16. Penumbra, Inc.
14.2.17. Simbionix USA Corporation
14.2.18. Sirtex Medical Limited
14.2.19. Stryker Corporation
14.2.20. Terumo Corporation
15. Strategic Recommendations
16. About Us & Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（二次医療）の最新刊レポート

TechSci Research社の二次医療分野での最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ（TechSci Research）は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.